Drug Metabolism and Pharmacokinetics, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Bioanalytical Department, Covance Laboratories, Inc., 3301 Kinsman Blvd, Madison, Wisconsin 53704, United States.
J Am Soc Mass Spectrom. 2021 Aug 4;32(8):2033-2049. doi: 10.1021/jasms.0c00435. Epub 2021 Apr 7.
Bile acids (BAs) are biomolecules synthesized in the liver from cholesterol and are constituents of bile. The BA pool includes more than 50 known diverse BAs which are unconjugated, amino acid conjugated, sulfated, and glucuronidated metabolites. Hemostasis of bile acids is known to be highly regulated and an interplay between liver metabolism, gut microbiome function, intestinal absorption, and enterohepatic recirculation. Interruption of BA homeostasis has been attributed to several metabolic diseases and drug induced liver injury (DILI), and their use as potential biomarkers is increasingly becoming important. Speciated quantitative and comprehensive profiling of BAs in various biomatrices from humans and preclinical animal species are important to understand their significance and biological function. Consequently, a versatile one single bioanalytical method for BAs is required to accommodate quantitation in a broad range of biomatrices from human and preclinical animal species. Here we report a versatile, comprehensive, and high throughput liquid chromatography-high resolution mass spectrometry (LC-HRMS) targeted metabolomics method for quantitative analysis of 50 different BAs in multiple matrices including human serum, plasma, and urine and plasma and urine of preclinical animal species (rat, rabbit, dog, and monkey). The method has been sufficiently qualified for accuracy, precision, robustness, and ruggedness and addresses the issue of nonspecific binding of bile acids to plastic for urine samples. Application of this method includes comparison for BA analysis between matched plasma and serum samples, human and animal species differences in BA pools, data analysis, and visualization of complex BA data using BA indices or ratios to understand BA biology, metabolism, and transport.
胆汁酸(BAs)是肝脏中从胆固醇合成的生物分子,是胆汁的组成部分。BA 池包括 50 多种已知的不同胆汁酸,它们是非结合的、氨基酸结合的、硫酸化的和葡萄糖醛酸化的代谢物。已知胆汁酸的止血作用受到高度调节,这是肝脏代谢、肠道微生物组功能、肠道吸收和肠肝再循环之间相互作用的结果。BA 动态平衡的中断与几种代谢疾病和药物性肝损伤(DILI)有关,它们作为潜在生物标志物的用途越来越重要。在人类和临床前动物物种的各种生物基质中对胆汁酸进行特定定量和全面分析对于了解它们的意义和生物学功能非常重要。因此,需要一种多功能的单一生物分析方法来适应人类和临床前动物物种的广泛生物基质中的定量分析。在这里,我们报告了一种多功能、全面和高通量的液相色谱-高分辨率质谱(LC-HRMS)靶向代谢组学方法,用于定量分析 50 种不同的胆汁酸在多种基质中,包括人血清、血浆和尿液以及临床前动物物种(大鼠、兔、狗和猴)的血浆和尿液。该方法已经充分具备准确性、精密度、稳健性和耐用性,并解决了胆汁酸与尿液样本塑料非特异性结合的问题。该方法的应用包括比较匹配的血浆和血清样本中的 BA 分析、BA 池在人类和动物物种之间的差异、数据分析以及使用 BA 指数或比值来可视化复杂的 BA 数据,以了解 BA 的生物学、代谢和运输。